TRACK BRANDS ON AI
Monitor your brand, company, or product's online reputation in AI responses
Searching...
Loading...
It's taking longer than usual, we might be experiencing higher load.
Give it a few more seconds or try again in a moment.
Give it a few more seconds or try again in a moment.
Searching...
Loading...
What does AI know about Larimar Therapeutics Inc?
What does OpenAI free version (gpt-3.5-turbo) know about Larimar Therapeutics Inc?
| Last request | 27.01.2024
(There is a high chance that below response is an AI hallucination) |
| Well Known | No |
| Description | Larimar Therapeutics Inc is a biotechnology company focused on developing novel treatments for rare genetic diseases. |
| Most Notable Achievements | Larimar Therapeutics Inc has a strong pipeline of potential therapies that have shown promising results in preclinical studies. |
| The Most Negative Fact | The company is relatively new and has not yet brought any products to market. |
| Competition | None |
| Share with friends |
Register your email below to unlock features!
Don't like the AI answers? Who can help me Change them?
What does OpenAI paid version (gpt-4) know about Larimar Therapeutics Inc?
| Request date | |
| Well Known | No |
| Description | Larimar Therapeutics Inc. is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. |
| Most Notable Achievements | The company is pioneering the development of a potential treatment for Friedreich's Ataxia, a rare genetic disease with no current cure. |
| The Most Negative Fact | The company's lead product candidate, CTI-1601, received a clinical hold from the FDA in 2021, delaying its development. |
| Competition | |
| Share with friends |
What does Google AI (PaLM) know about Larimar Therapeutics Inc?
| Last request | 27.01.2024 |
| Well Known | no |
| Description | Larimar Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of cancer. |
| Most Notable Achievements | The company's lead product candidate, LARIMAR-01, is a novel, first-in-class, oral, small molecule inhibitor of the aryl hydrocarbon receptor (AHR) that is currently in Phase 1 clinical development for the treatment of patients with advanced solid tumors. |
| The Most Negative Fact | The company has a limited financial history and has not yet generated any revenue. |
| Competition | None |
What does Microsoft Bing AI know about Larimar Therapeutics Inc?
| Well Known | No |
| Description | yoe pabsttsctvoe ceripae Ts nsti.esm ifdLnoeelrp ord cgd cah fyaooean etIra c i eerlaovuihntlcmnuisenonrmn ais rgoege |
| Most Notable Achievements | ii fh. rtprLssatael s i og rni c oseuiitcahieuo du enrntenIt leeetpaieo Trisairaslna t hvpetahmsnpprtopw psrnmcecihl sa s nilga h |
| The Most Negative Fact | m tntstml bToays k cira ocghrw tseplvteaueep tann onte .y hieyuhadoodr yran |
| Competition | eonN |
Register your email below to unlock features!
Looks like you haven't registered an account yet?
Just search for a brand, person or top-list BELOW and register your email on the search results page:
